➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Merck
Mallinckrodt
Colorcon
AstraZeneca

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

NALLPEN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Nallpen patents expire, and what generic alternatives are available?

Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in NALLPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Nallpen

A generic version of NALLPEN was approved as nafcillin sodium by SANDOZ on August 2nd, 1984.

  Start Trial

Summary for NALLPEN
Drug patent expirations by year for NALLPEN

US Patents and Regulatory Information for NALLPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline NALLPEN nafcillin sodium INJECTABLE;INJECTION 061999-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare NALLPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050655-002 Oct 31, 1989 RX Yes Yes   Start Trial   Start Trial   Start Trial
Glaxosmithkline NALLPEN nafcillin sodium INJECTABLE;INJECTION 062755-002 Dec 19, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
AstraZeneca
Baxter
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.